Luke Sergott
Stock Analyst at Barclays
(2.15)
# 2,835
Out of 4,947 analysts
306
Total ratings
40.35%
Success rate
-5.66%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Overweight | $190 → $210 | $163.02 | +28.82% | 4 | Aug 8, 2025 | |
| TXG 10x Genomics | Maintains: Overweight | $13 → $15 | $13.36 | +12.28% | 13 | Aug 8, 2025 | |
| FTRE Fortrea Holdings | Maintains: Underweight | $5 → $6 | $8.04 | -25.37% | 11 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $65 → $55 | $45.60 | +20.61% | 6 | Aug 7, 2025 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $155 → $165 | $156.68 | +5.31% | 8 | Aug 7, 2025 | |
| BRKR Bruker | Maintains: Overweight | $46 → $43 | $33.52 | +28.28% | 5 | Aug 4, 2025 | |
| AVTR Avantor | Maintains: Overweight | $15 → $13 | $12.93 | +0.54% | 25 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Underweight | $85 → $90 | $100.11 | -10.10% | 19 | Aug 1, 2025 | |
| INCY Incyte | Initiates: Overweight | $90 | $86.92 | +3.54% | 1 | Aug 1, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Equal-Weight | $155 → $180 | $175.99 | +2.28% | 20 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $450 → $490 | $489.01 | +0.20% | 26 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $300 → $450 | $457.85 | -1.71% | 2 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $185 | $191.09 | -3.19% | 23 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2 → $1.5 | $1.31 | +14.50% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $15.74 | -17.41% | 21 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $215 → $225 | $210.93 | +6.67% | 40 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $115 → $125 | $119.20 | +4.87% | 9 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $245 | $246.20 | -0.49% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $150 | $124.35 | +20.63% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $55 | $49.35 | +11.45% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,325 | $1,312.34 | +0.96% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $11 → $14 | $11.02 | +27.04% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 → $60 | $58.88 | +1.90% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $291.55 | +20.05% | 18 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $45 | $28.12 | +60.03% | 17 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $110 | $90.78 | +21.17% | 9 | Apr 10, 2025 |
Natera
Aug 8, 2025
Maintains: Overweight
Price Target: $190 → $210
Current: $163.02
Upside: +28.82%
10x Genomics
Aug 8, 2025
Maintains: Overweight
Price Target: $13 → $15
Current: $13.36
Upside: +12.28%
Fortrea Holdings
Aug 7, 2025
Maintains: Underweight
Price Target: $5 → $6
Current: $8.04
Upside: -25.37%
Exact Sciences
Aug 7, 2025
Maintains: Overweight
Price Target: $65 → $55
Current: $45.60
Upside: +20.61%
Charles River Laboratories International
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $155 → $165
Current: $156.68
Upside: +5.31%
Bruker
Aug 4, 2025
Maintains: Overweight
Price Target: $46 → $43
Current: $33.52
Upside: +28.28%
Avantor
Aug 4, 2025
Maintains: Overweight
Price Target: $15 → $13
Current: $12.93
Upside: +0.54%
Illumina
Aug 1, 2025
Maintains: Underweight
Price Target: $85 → $90
Current: $100.11
Upside: -10.10%
Incyte
Aug 1, 2025
Initiates: Overweight
Price Target: $90
Current: $86.92
Upside: +3.54%
ICON Public Limited Company
Jul 25, 2025
Maintains: Equal-Weight
Price Target: $155 → $180
Current: $175.99
Upside: +2.28%
Jul 24, 2025
Maintains: Equal-Weight
Price Target: $450 → $490
Current: $489.01
Upside: +0.20%
Jul 23, 2025
Maintains: Equal-Weight
Price Target: $300 → $450
Current: $457.85
Upside: -1.71%
Jul 23, 2025
Maintains: Equal-Weight
Price Target: $165 → $185
Current: $191.09
Upside: -3.19%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $2 → $1.5
Current: $1.31
Upside: +14.50%
Jun 24, 2025
Maintains: Overweight
Price Target: $15 → $13
Current: $15.74
Upside: -17.41%
Jun 24, 2025
Maintains: Overweight
Price Target: $215 → $225
Current: $210.93
Upside: +6.67%
Jun 24, 2025
Maintains: Equal-Weight
Price Target: $115 → $125
Current: $119.20
Upside: +4.87%
Jun 24, 2025
Initiates: Equal-Weight
Price Target: $245
Current: $246.20
Upside: -0.49%
Jun 24, 2025
Initiates: Overweight
Price Target: $150
Current: $124.35
Upside: +20.63%
Jun 24, 2025
Initiates: Overweight
Price Target: $55
Current: $49.35
Upside: +11.45%
Jun 24, 2025
Initiates: Overweight
Price Target: $1,325
Current: $1,312.34
Upside: +0.96%
May 8, 2025
Upgrades: Overweight
Price Target: $11 → $14
Current: $11.02
Upside: +27.04%
May 1, 2025
Maintains: Overweight
Price Target: $55 → $60
Current: $58.88
Upside: +1.90%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $291.55
Upside: +20.05%
Apr 10, 2025
Maintains: Overweight
Price Target: $58 → $45
Current: $28.12
Upside: +60.03%
Apr 10, 2025
Maintains: Overweight
Price Target: $140 → $110
Current: $90.78
Upside: +21.17%